I have been keenly looking at BST. Today there has been a disappointing announcement.
In Feb they predicted NPAT for 2H23 to be $18-$20M. Today they announce that is likely to be $10-$12M even though total sales are slightly up on PCP.
I'm disappointed that management didn't explain that on the same sales they can get the NPAT estimate wrong by 40%. Why the unexpected jump in costs when they are expecting product and shipping costs to ease for next FY? Maybe they expecting lower sales too but there is no explanation given.